These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
282 related articles for article (PubMed ID: 33573560)
1. The Anti-Tumor Mechanism and Target of Triptolide Based on Network Pharmacology and Molecular Docking. Zou T; Huang Y; Hu Y; Wu M; Zhao Y; Du F; Li M; Wu X; Ji H; Kaboli PJ; Wang S; Xiao Z; Wu Z Recent Pat Anticancer Drug Discov; 2021; 16(3):426-435. PubMed ID: 33573560 [TBL] [Abstract][Full Text] [Related]
2. Prediction of triptolide targets in rheumatoid arthritis using network pharmacology and molecular docking. Song X; Zhang Y; Dai E; Wang L; Du H Int Immunopharmacol; 2020 Mar; 80():106179. PubMed ID: 31972422 [TBL] [Abstract][Full Text] [Related]
3. Triptolide is a Promising Therapeutic Approach in Treating Thyroid Cancer Based on in silico and in vitro Experiment. Wang F; An SJ; Yin Y; Li JJ; Sun CH; Lan J; Zhao WJ; Li CQ Drug Des Devel Ther; 2021; 15():4275-4287. PubMed ID: 34703209 [TBL] [Abstract][Full Text] [Related]
4. Triptolide exerts an anti-tumor effect on non‑small cell lung cancer cells by inhibiting activation of the IL‑6/STAT3 axis. Huang Y; Chen Z; Wang Y; Ba X; Huang Y; Shen P; Wang H; Tu S Int J Mol Med; 2019 Jul; 44(1):291-300. PubMed ID: 31115521 [TBL] [Abstract][Full Text] [Related]
5. Combined Treatment with Triptolide and Tyrosine Kinase Inhibitors Synergistically Enhances Apoptosis in Non-small Cell Lung Cancer H1975 Cells but Not H1299 Cells through EGFR/Akt Pathway. Tong X; Jiang P; Li Y; Guo L; Zhang HM; Zhang BK; Yan M Chem Pharm Bull (Tokyo); 2019 Aug; 67(8):864-871. PubMed ID: 31142691 [TBL] [Abstract][Full Text] [Related]
6. Potential Mechanisms of Triptolide against Diabetic Cardiomyopathy Based on Network Pharmacology Analysis and Molecular Docking. Zhu N; Huang B; Zhu L; Wang Y J Diabetes Res; 2021; 2021():9944589. PubMed ID: 34926700 [TBL] [Abstract][Full Text] [Related]
7. [Advances on effects of triptolide with non-small cell lung cancer]. Wang L; Song Y Zhongguo Fei Ai Za Zhi; 2013 Jul; 16(7):378-81. PubMed ID: 23866670 [TBL] [Abstract][Full Text] [Related]
8. Triptolide as a novel agent in pancreatic cancer: the validation using patient derived pancreatic tumor cell line. Kim ST; Kim SY; Lee J; Kim K; Park SH; Park YS; Lim HY; Kang WK; Park JO BMC Cancer; 2018 Nov; 18(1):1103. PubMed ID: 30419860 [TBL] [Abstract][Full Text] [Related]
9. Antitumor activity of triptolide in SKOV3 cells and SKOV3/DDP in vivo and in vitro. Hu H; Zhu S; Tong Y; Huang G; Tan B; Yang L Anticancer Drugs; 2020 Jun; 31(5):483-491. PubMed ID: 31972592 [TBL] [Abstract][Full Text] [Related]
10. A Network Pharmacology-Based Strategy for Unveiling the Mechanisms of Tripterygium Wilfordii Hook F against Diabetic Kidney Disease. Wang Y; Liu T; Ma F; Lu X; Mao H; Zhou W; Yang L; Li P; Zhan Y J Diabetes Res; 2020; 2020():2421631. PubMed ID: 33274236 [TBL] [Abstract][Full Text] [Related]
11. Elucidating the mechanism of action of Isobavachalcone induced autophagy and apoptosis in non-small cell lung cancer by network pharmacology and experimental validation methods. Wang L; Wang Z; Ni Y; Wang X; Zhang T; Hu M; Lian C; Wang X; Zhang J Gene; 2024 Aug; 918():148474. PubMed ID: 38670393 [TBL] [Abstract][Full Text] [Related]
12. Network pharmacology of triptolide in cancer cells: implications for transcription factor binding. Seo EJ; Dawood M; Hult AK; Olsson ML; Efferth T Invest New Drugs; 2021 Dec; 39(6):1523-1537. PubMed ID: 34213719 [TBL] [Abstract][Full Text] [Related]
13. ITRAQ-Based Proteomics Analysis of Triptolide On Human A549 Lung Adenocarcinoma Cells. Li F; Zhao D; Yang S; Wang J; Liu Q; Jin X; Wang W Cell Physiol Biochem; 2018; 45(3):917-934. PubMed ID: 29428961 [TBL] [Abstract][Full Text] [Related]
14. Triptolide-induced cell death in pancreatic cancer is mediated by O-GlcNAc modification of transcription factor Sp1. Banerjee S; Sangwan V; McGinn O; Chugh R; Dudeja V; Vickers SM; Saluja AK J Biol Chem; 2013 Nov; 288(47):33927-33938. PubMed ID: 24129563 [TBL] [Abstract][Full Text] [Related]
15. Triptolide reverses hypoxia-induced epithelial-mesenchymal transition and stem-like features in pancreatic cancer by NF-κB downregulation. Liu L; Salnikov AV; Bauer N; Aleksandrowicz E; Labsch S; Nwaeburu C; Mattern J; Gladkich J; Schemmer P; Werner J; Herr I Int J Cancer; 2014 May; 134(10):2489-503. PubMed ID: 24615157 [TBL] [Abstract][Full Text] [Related]
16. Triptolide inhibits Wnt signaling in NSCLC through upregulation of multiple Wnt inhibitory factors via epigenetic modifications to Histone H3. Nardi I; Reno T; Yun X; Sztain T; Wang J; Dai H; Zheng L; Shen B; Kim J; Raz D Int J Cancer; 2018 Nov; 143(10):2470-2478. PubMed ID: 30006924 [TBL] [Abstract][Full Text] [Related]
17. The mechanism of triptolide in the treatment of connective tissue disease-related interstitial lung disease based on network pharmacology and molecular docking. Zhu W; Li Y; Zhao J; Wang Y; Li Y; Wang Y Ann Med; 2022 Dec; 54(1):541-552. PubMed ID: 35132912 [TBL] [Abstract][Full Text] [Related]
18. Targeted inhibition of the HNF1A/SHH axis by triptolide overcomes paclitaxel resistance in non-small cell lung cancer. Li LB; Yang LX; Liu L; Liu FR; Li AH; Zhu YL; Wen H; Xue X; Tian ZX; Sun H; Li PC; Zhao XG Acta Pharmacol Sin; 2024 May; 45(5):1060-1076. PubMed ID: 38228910 [TBL] [Abstract][Full Text] [Related]
19. Triptolide induces apoptosis through the calcium/calmodulin‑dependent protein kinase kinaseβ/AMP‑activated protein kinase signaling pathway in non‑small cell lung cancer cells. Ren T; Tang YJ; Wang MF; Wang HS; Liu Y; Qian X; Chang C; Chen MW Oncol Rep; 2020 Nov; 44(5):2288-2296. PubMed ID: 33000264 [TBL] [Abstract][Full Text] [Related]
20. Triptolide Modulates TREM-1 Signal Pathway to Inhibit the Inflammatory Response in Rheumatoid Arthritis. Fan D; He X; Bian Y; Guo Q; Zheng K; Zhao Y; Lu C; Liu B; Xu X; Zhang G; Lu A Int J Mol Sci; 2016 Apr; 17(4):498. PubMed ID: 27049384 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]